Advertisement

Topics

The End Of Generics Mergers? Too Much Effort, No Reward!

23:44 EDT 3 Jul 2017 | SCRIP

There has been $150bn worth of merger and acquisition activity since 2012 in the generic medicines arena, yet the sector...

      

Related Stories

 

Original Article: The End Of Generics Mergers? Too Much Effort, No Reward!

NEXT ARTICLE

More From BioPortfolio on "The End Of Generics Mergers? Too Much Effort, No Reward!"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...